Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00091689
Status:
COMPLETED
Last Update Posted:
2008-10-27
First Post:
2004-09-15
Brief Title:
Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-09
Start Date Type:
None
Primary Completion Date:
2006-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-01
Completion Date Type:
ACTUAL
First Submit Date:
2004-09-15
First Submit QC Date:
September 16 2004
Study First Post Date:
2004-09-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-10-24
Last Update Post Date:
2008-10-27
Last Update Post Date Type:
ESTIMATED